Navigation Links
Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
Date:5/9/2013

(PRWEB) May 09, 2013

For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuits because they suffered from Lipitor-induced diabetes.

Pfizer lost patent protection for Lipitor in 2011, which led to other manufacturers’ selling cheaper generic versions of the drug. Given the great number of Lipitor users, that switch to generic plays a large role in reduced spending, according to a May 9 Reuters report.

But despite the availability of inexpensive Lipitor, Rottenstein Law Group LLP principal Rochelle Rottenstein notes that studies have been released that indicate there could be some serious risks that go along with using Lipitor. She cites a January 2012 study in JAMA: Internal Medicine that indicated there is a potential link between statins and a Type 2 diabetes risk in women.**

“Even though generics present a cheaper alternative, there are still some people buying name-brand Lipitor,” Rottenstein said. “Those people are at risk of suffering the alleged side effects that could make them eligible to file a lawsuit.”

Plaintiffs across the United States have filed lawsuits, many of which are under consideration for consolidation into a multidistrict litigation for efficient pretrial proceedings (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)).

The Rottenstein Law Group LLP’s Lipitor Lawsuit Information Center offers a comprehensive look at Lipitor side effects and how to file a Lipitor lawsuit.

*reuters.com/article/2013/05/09/us-drugs-us-spending-idUSBRE94804W20130509

**archinte.jamanetwork.com/article.aspx?articleid=1108676

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at http://www.injurylawyernewswire.com. Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at http://www.prweb.com/releases/lipitor-recall/side-effects-lipitor/prweb10719174.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
2. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
3. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
4. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
5. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
6. New Lawsuit Alleges Teen Molestation by Ex-Deputy
7. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
8. New Lawsuit on Propecia: Severe Adverse Events
9. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
10. New Lawsuit alleges Actos caused Bladder Cancer
11. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology: